Home » Topics » Gastrointestinal, BioWorld Science

Gastrointestinal, BioWorld Science
RSS

Preclinical evidence supports delivery of HNF4A mRNA NPs to attenuate liver fibrosis and cirrhosis

Sep. 16, 2021

Curadev Pharma presents new STING antagonists

Sep. 7, 2021

New DGAT-2 inhibitors discovered at Inorbit Therapeutics

Sep. 7, 2021

MKK-4 inhibition for liver regeneration

Aug. 27, 2021

Hepagene reports phase I data on FXR agonist HPG-1860

Aug. 24, 2021

Phase IIb study of izencitinib in ulcerative colitis misses primary endpoint

Aug. 24, 2021

Phase II topline data show efficacy of MS-1819 plus PERT in severe exocrine pancreatic insufficiency

Aug. 19, 2021

Preclinical toxicology study supports development of antidiarrheal lechlemer

Aug. 18, 2021

Inhibitors of TNF-alpha- and IL-6-induced adhesion show activity in IBD models

Aug. 17, 2021

HepaRegeniX initiates first-in-human trial of HRX-0215

Aug. 12, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 17, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...